{
  "Version": 79,
  "ExpressionProfiles": [
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "CYP2D6",
      "Category": "Healthy",
      "Parameters": [
        {
          "Path": "CYP2D6|Reference concentration",
          "Value": 0.4,
          "Unit": "µmol/l"
        },
        {
          "Path": "CYP2D6|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "CYP2D6|t1/2 (liver)",
          "Value": 51.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Brain|Intracellular|CYP2D6|Relative expression",
          "Value": 0.00768702814
        },
        {
          "Path": "Organism|Gonads|Intracellular|CYP2D6|Relative expression",
          "Value": 0.768702814
        },
        {
          "Path": "Organism|Kidney|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0208304736
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|CYP2D6|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|CYP2D6|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0223404255
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP2D6|Relative expression",
          "Value": 0.0909402883
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome",
      "Ontogeny": {
        "Name": "CYP2D6"
      }
    },
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "CYP1A2",
      "Category": "Healthy",
      "Parameters": [
        {
          "Path": "CYP1A2|Reference concentration",
          "Value": 1.8,
          "Unit": "µmol/l"
        },
        {
          "Path": "CYP1A2|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "CYP1A2|t1/2 (liver)",
          "Value": 39.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Gonads|Intracellular|CYP1A2|Relative expression",
          "Value": 0.00029559748428
        },
        {
          "Path": "Organism|Kidney|Intracellular|CYP1A2|Relative expression",
          "Value": 4.4025157233E-06
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|CYP1A2|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|CYP1A2|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|CYP1A2|Relative expression",
          "Value": 2.4947589099E-05
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome",
      "Ontogeny": {
        "Name": "CYP1A2"
      }
    },
    {
      "Type": "Enzyme",
      "Species": "Human",
      "Molecule": "CYP2C19",
      "Category": "Healthy",
      "Parameters": [
        {
          "Path": "CYP2C19|Reference concentration",
          "Value": 0.76,
          "Unit": "µmol/l"
        },
        {
          "Path": "CYP2C19|t1/2 (intestine)",
          "Value": 23.0,
          "Unit": "h"
        },
        {
          "Path": "CYP2C19|t1/2 (liver)",
          "Value": 26.0,
          "Unit": "h"
        },
        {
          "Path": "Organism|Brain|Intracellular|CYP2C19|Relative expression",
          "Value": 0.00014961101137
        },
        {
          "Path": "Organism|Gonads|Intracellular|CYP2C19|Relative expression",
          "Value": 0.0003526545268
        },
        {
          "Path": "Organism|Kidney|Intracellular|CYP2C19|Relative expression",
          "Value": 0.00015816021202
        },
        {
          "Path": "Organism|Liver|Pericentral|Intracellular|CYP2C19|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Liver|Periportal|Intracellular|CYP2C19|Relative expression",
          "Value": 1.0
        },
        {
          "Path": "Organism|Lung|Intracellular|CYP2C19|Relative expression",
          "Value": 0.00040608703086
        },
        {
          "Path": "Organism|SmallIntestine|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        },
        {
          "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP2C19|Relative expression",
          "Value": 0.3238009746
        }
      ],
      "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome",
      "Ontogeny": {
        "Name": "CYP2C19"
      }
    }
  ],
  "Individuals": [
    {
      "Name": "Todor 2017, n=18",
      "Seed": 371188921,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Parameters": [
        {
          "Path": "Organism|Liver|EHC continuous fraction",
          "Value": 1.0
        }
      ],
      "ExpressionProfiles": [
        "CYP2D6|Human|Healthy",
        "CYP1A2|Human|Healthy",
        "CYP2C19|Human|Healthy"
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Atomoxetine",
      "IsSmallMolecule": true,
      "PlasmaProteinBindingPartner": "Albumin",
      "Lipophilicity": [
        {
          "Name": "LogP",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.4885087539,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Lipophilicity, fu, kcat CYP2C19, intestinal perm no sp cl.' on 2021-11-16 08:40"
              }
            }
          ]
        },
        {
          "Name": "Mohan 2015",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.65,
              "Unit": "Log Units"
            }
          ]
        },
        {
          "Name": "ChemAxon",
          "IsDefault": false,
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.81,
              "Unit": "Log Units"
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 1.3,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVivo",
                "Description": "Yu 2016"
              }
            }
          ]
        },
        {
          "Name": "Calculated",
          "IsDefault": false,
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 3.9,
              "Unit": "%",
              "ValueOrigin": {
                "Source": "Unknown",
                "Description": "Watanabe 2018"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 10.29,
              "Unit": "mg/ml",
              "ValueOrigin": {
                "Source": "Unknown",
                "Description": "chemicalize - atomoxetine hydrochloride"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.4,
              "ValueOrigin": {
                "Source": "Unknown",
                "Description": "chemicalize - atomoxetine hydrochloride"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 5.23E-05,
              "Unit": "cm/min"
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 9.8,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Ring 2001 (4-hydroxylation)",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 115.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 10.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 2.3,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 37.4392066898,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Lipophilicity, fu, kcat CYP2C19, intestinal perm no sp cl.' on 2021-11-16 08:40"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "AS=0",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 10.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 2.3,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "Assumed",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "AS=2",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 10.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 2.3,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 102.25,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Other",
                "Method": "ManualFit",
                "Description": "AS-Model"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "AS=0.5",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 10.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 2.3,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 16.87,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Other",
                "Method": "ManualFit",
                "Description": "AS-Model"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "AS=1.25",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 10.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 2.3,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 53.68,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Other",
                "Method": "ManualFit",
                "Description": "AS-Model"
              }
            }
          ]
        },
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Ring 2002",
          "Molecule": "CYP2C19",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 97.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 19.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 83.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 165.2291488831,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Lipophilicity, fu, kcat CYP2C19, intestinal perm no sp cl.' on 2021-11-16 08:40"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Sauer 2004",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 3.6,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Unknown",
                "Description": "Sauer 2004"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Sauer 2004",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 34.0,
              "Unit": "µmol/l"
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Berezhkovskiy",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 255.35,
          "Unit": "g/mol"
        }
      ]
    },
    {
      "Name": "Fluvoxamine",
      "IsSmallMolecule": true,
      "Lipophilicity": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 3.5726507829,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.23,
              "ValueOrigin": {
                "Source": "Publication",
                "Description": "Claassen et al., Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br. J. Clin. Pharmacol. 15, 349S-355S (1983)."
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 14.66,
              "Unit": "mg/ml"
            },
            {
              "Name": "Reference pH",
              "Value": 7.0
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Fitted",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 2.7380788903E-06,
              "Unit": "dm/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 9.4,
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationLiverMicrosomes_MM",
          "DataSource": "Fit",
          "Molecule": "CYP1A2",
          "Parameters": [
            {
              "Name": "In vitro Vmax for liver microsomes",
              "Value": 0.0,
              "Unit": "pmol/min/mg mic. protein"
            },
            {
              "Name": "Content of CYP proteins in liver microsomes",
              "Value": 45.0,
              "Unit": "pmol/mg mic. protein",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Km",
              "Value": 0.0073460807948,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 0.0155447966,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "InternalName": "rCYP450_MM",
          "DataSource": "Miura2007",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "In vitro Vmax/recombinant enzyme",
              "Value": 0.69,
              "Unit": "pmol/min/pmol rec. enzyme"
            },
            {
              "Name": "Km",
              "Value": 76.3,
              "Unit": "µmol/l"
            },
            {
              "Name": "kcat",
              "Value": 110.5561921693,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification"
              }
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "4% Urine",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 1.0
            }
          ]
        },
        {
          "InternalName": "MixedInhibition",
          "DataSource": "Karjalainen2008/Yao2001",
          "Molecule": "CYP1A2",
          "Parameters": [
            {
              "Name": "Ki_c",
              "Value": 10.0,
              "Unit": "nmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Karjalainen et al. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin. Pharmacol. Toxicol. 103, 157–65 (2008) and Yao, C. et al. Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clin. Pharmacol. Ther. 70, 415–24 (2001)"
              }
            },
            {
              "Name": "Ki_u",
              "Value": 10.0,
              "Unit": "nmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Karjalainen et al. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin. Pharmacol. Toxicol. 103, 157–65 (2008) and Yao, C. et al. Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clin. Pharmacol. Ther. 70, 415–24 (2001)"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Olesen2000/Yao2001",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 1.6,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Olesen et al. Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism. J. Clin. Psychopharmacol. 20, 35–42 (2000) and Yao, C. et al. Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clin. Pharmacol. Ther. 70, 415–24 (2001)"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Crewe 1992",
          "Molecule": "CYP2D6",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 8.2,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Crewe 1992"
              }
            }
          ]
        },
        {
          "InternalName": "CompetitiveInhibition",
          "DataSource": "Iga 2016",
          "Molecule": "CYP2C19",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 3.6,
              "Unit": "nM",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Iga 2016 (omeprazole)"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Schmitt",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "F",
          "Value": 3.0
        },
        {
          "Name": "Molecular weight",
          "Value": 318.335,
          "Unit": "g/mol"
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Atomoxetine (Weibull, Strattera Lilly)",
      "FormulationType": "Formulation_Tablet_Lint80",
      "Parameters": [
        {
          "Name": "Dissolution time (80% dissolved)",
          "Value": 5.0,
          "Unit": "min"
        },
        {
          "Name": "Lag time",
          "Value": 0.0,
          "Unit": "min"
        },
        {
          "Name": "Use as suspension",
          "Value": 1.0
        }
      ]
    },
    {
      "Name": "Solution",
      "FormulationType": "Formulation_Dissolved"
    }
  ],
  "Protocols": [
    {
      "Name": "Atomoxetine - po, 25 mg, sd",
      "ApplicationType": "Oral",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 25.0,
          "Unit": "mg"
        },
        {
          "Name": "Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ]
    },
    {
      "Name": "Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 36.64,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 3.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        },
        {
          "Name": "Schema 2",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 73.28,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 72.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 3.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "Todor 2015 - Atomoxetine - po, 25 mg, sd @ 120h",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 25.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h"
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 1.0
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 0.0,
              "Unit": "h"
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "Simulations": [
    {
      "Name": "Todor 2017 - Atomoxetine - po, 25 mg, sd n=18",
      "Model": "4Comp",
      "ObservedData": [
        "Todor 2017 - Atomoxetine - po, 25 mg, sd"
      ],
      "Solver": {
        "AbsTol": 1E-15,
        "RelTol": 1E-10
      },
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Atomoxetine - po, 25 mg, sd|Atomoxetine (Weibull, Strattera Lilly)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atomoxetine|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Todor 2017, n=18",
      "Compounds": [
        {
          "Name": "Atomoxetine",
          "CalculationMethods": [
            "Cellular partition coefficient method - Berezhkovskiy",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "LogP",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Measurement",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP2D6-Ring 2001 (4-hydroxylation)",
              "MoleculeName": "CYP2D6"
            },
            {
              "MoleculeName": "CYP1A2"
            },
            {
              "Name": "CYP2C19-Ring 2002",
              "MoleculeName": "CYP2C19"
            },
            {
              "Name": "Glomerular Filtration-Assumed",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Atomoxetine - po, 25 mg, sd",
            "Formulations": [
              {
                "Name": "Atomoxetine (Weibull, Strattera Lilly)",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Atomoxetine-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Todor 2017 - Atomoxetine - po, 25 mg, sd n=18|Organism|PeripheralVenousBlood|Atomoxetine|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3
              }
            },
            {
              "Name": "Todor et al._2017_ATX_EM, ATX Control-Atomoxetine-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Todor 2017 - Atomoxetine - po, 25 mg, sd|Time",
              "Y": "Todor 2017 - Atomoxetine - po, 25 mg, sd|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Fluvoxamine-Atomoxetine-DDI\nTodor 2017 - Atomoxetine - po, 25 mg, sd n=18\n2024-04-24 16:10"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP2D6-Sauer 2004",
          "MoleculeName": "CYP2D6",
          "CompoundName": "Atomoxetine"
        },
        {
          "MoleculeName": "CYP2D6"
        }
      ]
    },
    {
      "Name": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6 n=18",
      "Model": "4Comp",
      "ObservedData": [
        "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6"
      ],
      "Solver": {
        "AbsTol": 1E-15,
        "RelTol": 1E-10
      },
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 160.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|Todor 2015 - Atomoxetine - po, 25 mg, sd @ 120h|Atomoxetine (Weibull, Strattera Lilly)|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atomoxetine|Plasma (Peripheral Venous Blood)",
        "Organism|PeripheralVenousBlood|Fluvoxamine|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Todor 2017, n=18",
      "Compounds": [
        {
          "Name": "Atomoxetine",
          "CalculationMethods": [
            "Cellular partition coefficient method - Berezhkovskiy",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "LogP",
              "GroupName": "COMPOUND_LIPOPHILICITY"
            },
            {
              "AlternativeName": "Measurement",
              "GroupName": "COMPOUND_FRACTION_UNBOUND"
            },
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP2D6-Ring 2001 (4-hydroxylation)",
              "MoleculeName": "CYP2D6"
            },
            {
              "MoleculeName": "CYP1A2"
            },
            {
              "Name": "CYP2C19-Ring 2002",
              "MoleculeName": "CYP2C19"
            },
            {
              "Name": "Glomerular Filtration-Assumed",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Todor 2015 - Atomoxetine - po, 25 mg, sd @ 120h",
            "Formulations": [
              {
                "Name": "Atomoxetine (Weibull, Strattera Lilly)",
                "Key": "Formulation"
              }
            ]
          }
        },
        {
          "Name": "Fluvoxamine",
          "CalculationMethods": [
            "Cellular partition coefficient method - Schmitt",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Fitted",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP2D6-Miura2007",
              "MoleculeName": "CYP2D6"
            },
            {
              "Name": "CYP1A2-Fit",
              "MoleculeName": "CYP1A2"
            },
            {
              "MoleculeName": "CYP2C19"
            },
            {
              "Name": "Glomerular Filtration-4% Urine",
              "SystemicProcessType": "GFR"
            }
          ],
          "Protocol": {
            "Name": "Todor 2017 - Fluvoxamine - po, 50/100 mg, qd, 6 days",
            "Formulations": [
              {
                "Name": "Solution",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 113.3385,
              "Max": 151.0869,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": -6.744149,
              "Max": 284.0658,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Atomoxetine-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6 n=18|Organism|PeripheralVenousBlood|Atomoxetine|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 3
              }
            },
            {
              "Name": "Todor et al._2017_ATX_EM, ATX DDI Fluvoxamine-Atomoxetine-Peripheral Venous Blood-Plasma-Measurement",
              "X": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6|Time",
              "Y": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Measurement",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 4,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "FontAndSize": {
            "Fonts": {
              "AxisSize": 10,
              "LegendSize": 8,
              "TitleSize": 16,
              "DescriptionSize": 12,
              "OriginSize": 8,
              "FontFamilyName": "Microsoft Sans Serif",
              "WatermarkSize": 32
            }
          },
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#00FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Fluvoxamine-Atomoxetine-DDI\nTodor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6 n=18\n2024-04-24 16:12"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP2D6-Sauer 2004",
          "MoleculeName": "CYP2D6",
          "CompoundName": "Atomoxetine"
        },
        {
          "Name": "CYP2D6-Crewe 1992",
          "MoleculeName": "CYP2D6",
          "CompoundName": "Fluvoxamine"
        },
        {
          "Name": "CYP1A2-Karjalainen2008/Yao2001",
          "MoleculeName": "CYP1A2",
          "CompoundName": "Fluvoxamine"
        },
        {
          "Name": "CYP2C19-Iga 2016",
          "MoleculeName": "CYP2C19",
          "CompoundName": "Fluvoxamine"
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Todor 2017 - Atomoxetine - po, 25 mg, sd",
      "ExtendedProperties": [
        {
          "Name": "Molecule",
          "Value": "Atomoxetine"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Todor 2017 - Atomoxetine - po, 25 mg, sd|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 255.35
              },
              "Values": [
                72.943,
                64.294,
                32.147,
                34.742,
                19.028,
                34.164,
                53.771,
                60.401,
                49.1569977,
                42.5249977,
                35.462,
                15.1359987
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "ng/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Todor 2017 - Atomoxetine - po, 25 mg, sd|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 255.35
          },
          "Values": [
            145.11499,
            184.46199,
            169.75,
            166.571,
            145.372,
            148.247,
            146.647,
            108.702995,
            70.76,
            47.52,
            33.6509972,
            6.36699963
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Todor 2017 - Atomoxetine - po, 25 mg, sd|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          6.0,
          8.0,
          10.0,
          12.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6",
      "ExtendedProperties": [
        {
          "Name": "Molecule",
          "Value": "Atomoxetine"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        }
      ],
      "Columns": [
        {
          "Name": "Measurement",
          "RelatedColumns": [
            {
              "Name": "Error",
              "QuantityInfo": {
                "Path": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Error"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "MolWeight": 255.35
              },
              "Values": [
                87.510994,
                42.882,
                0.0,
                11.942,
                0.0,
                26.657,
                41.533,
                43.935,
                41.647,
                34.783,
                27.804,
                12.337
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "ng/ml"
            }
          ],
          "QuantityInfo": {
            "Path": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6|ObservedData|Peripheral Venous Blood|Plasma|Atomoxetine|Measurement"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "MolWeight": 255.35
          },
          "Values": [
            177.109009,
            235.569,
            252.78299,
            231.32,
            221.93,
            198.353012,
            190.327988,
            140.069,
            89.581,
            61.289,
            45.0109978,
            10.046
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Path": "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined"
        },
        "Values": [
          120.5,
          121.0,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          126.0,
          128.0,
          130.0,
          132.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    }
  ],
  "ObservedDataClassifications": [
    {
      "Name": "fluvoxamine ddi",
      "Classifiables": [
        "Todor 2017 - Atomoxetine - po, 25 mg, sd",
        "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6"
      ]
    }
  ],
  "SimulationClassifications": [
    {
      "Name": "fluvoxamine ddi",
      "Classifiables": [
        "Todor 2017 - Atomoxetine - po, 25 mg, sd n=18",
        "Todor 2017 - DDI - Fluvoxamine-Atomoxetine - po, 25 mg, sd, day 6 n=18"
      ]
    }
  ]
}